A recent meta-analysis carried out on 389 patients with clinical/biochemical suspicion of PCa documented for [68Ga]Ga-PSMA-11 PET an overall sensitivity and specificity of 97% and 66%, respectively. The gene discussed is FOLH1; the disease is posterior cortical atrophy.